Julie Hambleton Net Worth & Insider Trades

Julie Hambleton - Director, Igm Biosciences, Inc

As of March 15, 2022

What is Julie Hambleton's Net Worth?

The current estimated net worth of Igm Biosciences, Inc's Director, Julie Hambleton, is estimated to be about $1.38M . Julie Hambleton owns about 2,000 units of Igm Biosciences, Inc common stock. In the last 3 years at Igm Biosciences, Inc, Julie Hambleton has sold an estimated value of $240K worth.

What is Julie Hambleton's Past Insider Trading?

Julie Hambleton's largest purchase order was 5,000 units , worth over $91.55K on September 20, 2019. Julie Hambleton's largest sale order was 2,000 units , worth over $160K on June 3, 2021. In total, Julie Hambleton has made about 7 transactions over 3 years of their time at Igm Biosciences, Inc. Julie Hambleton usually trades in September and February, with the busiest year in 2021. The most recent transaction was a sale order of 1,000 units , worth over $80K on August 11, 2021.

Julie Hambleton

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

What is Julie Hambleton's' Mailing Address?

  • Mailing address is C/o Five Prime Therapeutics, Inc. Two Corporate Drive South San Francisco CA 94080 CA

Igm Biosciences, Inc Executive Compensation

Name
Year
Salary
Option Awards
Other Earnings Plans or Compensations
Total
Fred Schwarzer 2020 $529,700 $4,251,990 $317,820 $5,099,510
Fred Schwarzer 2019 $428,000 $121,189 $207,911 $757,100
Bruce Keyt, Ph.D. 2020 $413,200 $2,125,995 $223,128 $2,762,323
Bruce Keyt, Ph.D. 2019 $357,000 $92,714 $151,743 $601,457
Daniel S. Chen, M.D., Ph.D. 2020 $456,250 $1,559,063 $219,000 $2,234,313
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1496323/000119312521140868/d151412ddef14a.htm

What are Igm Biosciences, Inc's Past Insider Trades?

Igm Biosciences, Inc's most recent insider trade came on March 16, 2023 by Chris Takimoto who sold 1,768 units worth $33.12K . In the last 4 years, insiders at Igm Biosciences, Inc have sold an estimated value of $12.44M and bought an estimated value of $243.53M worth of shares. Insider trading is most common in March and September, with the busiest year in 2022. The most active traders at the company are Bruce Keyt, Chief Scientific Officer,  Haldor Jakob Topsoe, Director,  and Kathleen Behrens, Director .

IGM Biosciences, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...